Omeros Corporation (OMER)
NASDAQ: OMER
· Real-Time Price · USD
3.77
0.47 (14.24%)
At close: Jun 06, 2025, 3:59 PM
3.83
1.46%
After-hours: Jun 06, 2025, 05:54 PM EDT
14.24% (1D)
| Bid | 3.01 |
| Market Cap | 221.19M |
| Revenue (ttm) | 412K |
| Net Income (ttm) | -153.09M |
| EPS (ttm) | -3.04 |
| PE Ratio (ttm) | -1.24 |
| Forward PE | 11.28 |
| Analyst | Hold |
| Ask | 3.85 |
| Volume | 969,085 |
| Avg. Volume (20D) | 940,236 |
| Open | 3.44 |
| Previous Close | 3.30 |
| Day's Range | 3.40 - 3.85 |
| 52-Week Range | 2.97 - 13.60 |
| Beta | 2.20 |
About OMER
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OMER
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OMER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+3.89%
Omeros shares are trading after the company announ...
Unlock content with
Pro Subscription
5 months ago
+37.27%
Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit its narsoplimab Biologics License Application to the FDA.
